Client News

Posted: October 22, 2014, 10:09 pm
[AP] - A look at the 10 biggest percentage decliners on Nasdaq at the close of trading: Ohr Pharmaceutical fell 32.1 percent to $7.74. Web.com Inc. fell 19.9 percent to $27.70. Aemetis Inc. fell 12.5 percent ...
Posted: October 22, 2014, 10:09 pm
Posted: October 22, 2014, 10:09 pm
[at noodls] - NORTHBROOK, Ill., Oct. 22, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, ...
Posted: October 22, 2014, 1:47 pm
Posted: October 22, 2014, 1:41 pm
[GlobeNewswire] - NORTHBROOK, Ill. -- Nanosphere, Inc. (the "Company") , a leader in the development and commercialization of advanced molecular diagnostics systems, today announced the pricing of its previously ...
Posted: October 22, 2014, 1:00 pm
[at noodls] - For Immediate Release Outcomes Study Reports Use of MelaFind Reduced Benign Biopsies by 61% in Patients at Risk for Melanoma Irvington, NY,October 21, 2014- MELA Sciences, Inc. (NASDAQ: MELA), developer ...
Posted: October 22, 2014, 9:01 am
[at noodls] - CAMBRIDGE, Mass. and HERZLIYA PITUACH, Israel, Oct. 22, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (NASDAQ: IMNP; "Immune" or "the Company") announces that Dr. Tomer Adar , a ...
Posted: October 22, 2014, 7:44 am
[PR Newswire] - "Immune" or "the Company") announces that Dr. Tomer Adar, a gastro-enterologist at the Institute for Digestive Diseases at Shaare Zedek Medical Center, Israel, is presenting today at the United European Gastro-Enterology week in Vienna, Austria an abstract entitled "The importance of intestinal eotaxin-1 - Eosinophil axis in inflammatory bowel disease, Results of a prospective observational study." The study was supported in part by an unrestricted grant from Immune. Professor Eran Goldin, Chairman of the Institute for Digestive Diseases at Shaare Zedek Medical Center, part of the Hebrew University School of Medicine in Jerusalem, Israel, commented: "This prospective clinical observational study demonstrates the pivotal role of eotaxin-1 in both Ulcerative Colitis and Crohn's Disease.
Posted: October 22, 2014, 6:30 am
[at noodls] - NORTHBROOK, Ill., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company" or "Nanosphere") (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, ...
Posted: October 21, 2014, 9:03 pm
[GlobeNewswire] - NORTHBROOK, Ill. -- Nanosphere, Inc. (the "Company" or "Nanosphere") , a company enhancing medicine through targeted molecular diagnostics, today announced that it has commenced an ...
Posted: October 21, 2014, 8:01 pm
[at noodls] - Adult Mesenchymal Stem Cells Demonstrate Enhanced Survival and Recovery Following Cryopreservation with CryoStor, Reducing Research Costs and Expansion Time BOTHELL, WA- October 21, 2014 -BioLife Solutions, ...
Posted: October 21, 2014, 3:04 pm
[at noodls] - Alcobra - PR - 20140701 - KOL Event in NYC (B1741998).DOCX on October 23 in New York City Victoria, British Columbia - October 21st, 2014 -- Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH, Toronto Stock Exchange: ...
Posted: October 21, 2014, 2:44 pm
[at noodls] - REDWOOD CITY, Calif., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will report ...
Posted: October 21, 2014, 1:05 pm